Revenue
0 USD
2012 Q2 · USD
Exact inputs and evidence
- Revenue: 0 USD Source
Fundies. English
NEXUS BIOPHARMA INC
EDGAR40 filing records in this dataset, filed from 2008-05-05 to 2017-10-27. Reported financial figures are available; chart coverage varies by period.
Latest quarter
- Cash and cash equivalents
- 8.43 thousand USD Source
Exact value
8427 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 64.3 million shares Source
Exact value
64309656 shares
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Net income
-817 thousand USD
2016-06-01 – 2017-05-31
Exact inputs and evidence
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2017-10-27.
Financial data available through: 2017-02-28.
Coverage by financial measure
- revenue: No compatible figures in this window
- operating income: No compatible figures in this window
- Net income: 10 of 11 periods available· newest 2017-02-28
- Operating cash flow: 5 of 11 periods available· newest 2017-02-28
- capital expenditure: No compatible figures in this window
- Total assets: 8 of 11 periods available· newest 2017-02-28
- Total liabilities: 5 of 11 periods available· newest 2017-02-28
- Current assets: 5 of 11 periods available· newest 2017-02-28
- Current liabilities: 9 of 11 periods available· newest 2017-02-28
- Cash and cash equivalents: 7 of 11 periods available· newest 2017-02-28
- long term debt: No compatible figures in this window
- Shares outstanding: 7 of 11 periods available· newest 2017-02-28
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
+USD 466,804Prior period
−USD 1.15 million
–
Current period
−USD 686,100
–
Exact inputs and evidence
-686100 − -1152904 = 466804 USD
-1152904 USD · 2015-03-01 – 2016-02-29
Inspect prior input Prior source-686100 USD · 2016-03-01 – 2017-02-28
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 419,481Prior period
−USD 72,928
–
Current period
−USD 492,409
–
Exact inputs and evidence
-492409 − -72928 = -419481 USD
-72928 USD · 2015-03-01 – 2016-02-29
Inspect prior input Prior source-492409 USD · 2016-03-01 – 2017-02-28
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2008 2008-01-01 – 2008-12-31 | −USD 43,931 Exact valueExact value: -43931 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2009 2009-01-01 – 2009-12-31 | −USD 28,406 Exact valueExact value: -28406 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2010 2010-01-01 – 2010-12-31 | −USD 20,448 Exact valueExact value: -20448 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4,460 Exact valueExact value: -4460 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2011 2011-01-01 – 2011-12-31 | −USD 15,329 Exact valueExact value: -15329 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 24,035 Exact valueExact value: -24035 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2012 2012-01-01 – 2012-12-31 | −USD 9,376 Exact valueExact value: -9376 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2013 2013-01-01 – 2013-12-31 | −USD 15,261 Exact valueExact value: -15261 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 369 Exact valueExact value: -369 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2014 2014-01-01 – 2014-12-31 | −USD 1,400 Exact valueExact value: -1400 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2015 2015-01-01 – 2015-12-31 | −USD 41,846 Exact valueExact value: -41846 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2016 2015-03-01 – 2016-02-29 | −USD 1.15 million Exact valueExact value: -1152904 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 72,928 Exact valueExact value: -72928 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2017 2016-03-01 – 2017-02-28 | −USD 686,100 Exact valueExact value: -686100 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 492,409 Exact valueExact value: -492409 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
40 filings · 686 latest values · 686 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001424151, 1424151, NEXS, edgar:1424151, nexs
Also known as NEXUS BIOPHARMA INC, Plata Resources, Inc.